CYTOKINETICS INC Insider Trading for September 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CYTOKINETICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CYTOKINETICS INC for September 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Option Exercise | M | 6.67 | 1,432 | 9,551 | 2,659 | |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Option Exercise | M | 6.67 | 3,067 | 20,457 | 23,715 | |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Option Exercise | M | 6.37 | 5,732 | 36,513 | 18,857 | |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 15.00 | 100 | 1,500 | 18,369 | 18.5 K to 18.4 K (-0.54 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.95 | 707 | 10,570 | 18,469 | 19.2 K to 18.5 K (-3.69 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.93 | 400 | 5,970 | 19,176 | 19.6 K to 19.2 K (-2.04 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.90 | 600 | 8,940 | 19,576 | 20.2 K to 19.6 K (-2.97 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.85 | 724 | 10,751 | 20,176 | 20.9 K to 20.2 K (-3.46 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.83 | 100 | 1,483 | 20,900 | 21 K to 20.9 K (-0.48 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.80 | 400 | 5,920 | 21,000 | 21.4 K to 21 K (-1.87 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.78 | 400 | 5,910 | 21,400 | 21.8 K to 21.4 K (-1.83 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.75 | 600 | 8,850 | 21,800 | 22.4 K to 21.8 K (-2.68 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.73 | 200 | 2,945 | 22,400 | 22.6 K to 22.4 K (-0.88 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.70 | 500 | 7,350 | 22,600 | 23.1 K to 22.6 K (-2.16 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.65 | 200 | 2,930 | 23,100 | 23.3 K to 23.1 K (-0.86 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.63 | 300 | 4,388 | 23,300 | 23.6 K to 23.3 K (-1.27 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.60 | 700 | 10,220 | 23,600 | 24.3 K to 23.6 K (-2.88 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.58 | 200 | 2,915 | 24,300 | 24.5 K to 24.3 K (-0.82 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.53 | 200 | 2,905 | 24,500 | 24.7 K to 24.5 K (-0.81 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.50 | 200 | 2,900 | 24,700 | 24.9 K to 24.7 K (-0.80 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.48 | 200 | 2,895 | 24,900 | 25.1 K to 24.9 K (-0.80 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.45 | 600 | 8,670 | 25,100 | 25.7 K to 25.1 K (-2.33 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.40 | 400 | 5,760 | 25,700 | 26.1 K to 25.7 K (-1.53 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.38 | 200 | 2,875 | 26,100 | 26.3 K to 26.1 K (-0.76 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.35 | 200 | 2,870 | 26,300 | 26.5 K to 26.3 K (-0.75 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.30 | 302 | 4,319 | 26,500 | 26.8 K to 26.5 K (-1.13 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.28 | 100 | 1,428 | 26,802 | 26.9 K to 26.8 K (-0.37 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.25 | 400 | 5,700 | 26,902 | 27.3 K to 26.9 K (-1.47 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.20 | 898 | 12,752 | 27,302 | 28.2 K to 27.3 K (-3.18 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Buy | M | 6.37 | 5,732 | 36,513 | 28,200 | 22.5 K to 28.2 K (+25.51 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.15 | 200 | 2,830 | 22,468 | 22.7 K to 22.5 K (-0.88 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Buy | M | 6.67 | 3,067 | 20,457 | 22,668 | 19.6 K to 22.7 K (+15.65 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Sell | S | 14.10 | 200 | 2,820 | 19,601 | 19.8 K to 19.6 K (-1.01 %) |
| Sep 08 2017 | CYTK | CYTOKINETICS INC | McDowell Caryn Gordon | GC & Chief Complian ... | Buy | M | 6.67 | 1,432 | 9,551 | 19,801 | 18.4 K to 19.8 K (+7.80 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Option Exercise | M | 4.02 | 5,000 | 20,100 | 27,302 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Sell | S | 14.90 | 400 | 5,960 | 30,000 | 30.4 K to 30 K (-1.32 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Sell | S | 14.85 | 700 | 10,395 | 30,400 | 31.1 K to 30.4 K (-2.25 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Sell | S | 14.75 | 500 | 7,375 | 31,100 | 31.6 K to 31.1 K (-1.58 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Sell | S | 14.73 | 500 | 7,363 | 31,600 | 32.1 K to 31.6 K (-1.56 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Sell | S | 14.70 | 900 | 13,230 | 32,100 | 33 K to 32.1 K (-2.73 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Sell | S | 14.68 | 600 | 8,805 | 33,000 | 33.6 K to 33 K (-1.79 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Sell | S | 14.65 | 1,100 | 16,115 | 33,600 | 34.7 K to 33.6 K (-3.17 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Sell | S | 14.60 | 300 | 4,380 | 34,700 | 35 K to 34.7 K (-0.86 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | GAGE L PATRICK | Director | Buy | M | 4.02 | 5,000 | 20,100 | 35,000 | 30 K to 35 K (+16.67 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 15.28 | 100 | 1,528 | 74,885 | 75 K to 74.9 K (-0.13 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.90 | 400 | 5,960 | 74,985 | 75.4 K to 75 K (-0.53 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.80 | 200 | 2,960 | 75,385 | 75.6 K to 75.4 K (-0.26 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.75 | 100 | 1,475 | 75,585 | 75.7 K to 75.6 K (-0.13 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.73 | 300 | 4,418 | 75,685 | 76 K to 75.7 K (-0.39 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.70 | 1,300 | 19,110 | 75,985 | 77.3 K to 76 K (-1.68 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.68 | 800 | 11,740 | 77,285 | 78.1 K to 77.3 K (-1.02 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.65 | 1,200 | 17,580 | 78,085 | 79.3 K to 78.1 K (-1.51 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.63 | 100 | 1,463 | 79,285 | 79.4 K to 79.3 K (-0.13 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.60 | 400 | 5,840 | 79,385 | 79.8 K to 79.4 K (-0.50 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Blum Robert I | President & CEO | Sell | S | 14.55 | 100 | 1,455 | 79,785 | 79.9 K to 79.8 K (-0.13 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | COSTA SANTO J | Director | Option Exercise | M | 4.44 | 5,000 | 22,200 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | COSTA SANTO J | Director | Sell | S | 15.00 | 5,000 | 75,000 | 0 | 5 K to 0 (-100.00 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | COSTA SANTO J | Director | Buy | M | 4.44 | 5,000 | 22,200 | 5,000 | 0 to 5 K |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 11.10 | 695 | 7,715 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 11.10 | 694 | 7,703 | 695 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 9.65 | 11,552 | 111,477 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 9.42 | 617 | 5,812 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 7.96 | 15,206 | 121,040 | 3,750 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 6.67 | 16,666 | 111,162 | 14,517 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 6.30 | 1,079 | 6,798 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 6.00 | 3,795 | 22,770 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 11.10 | 2,638 | 29,282 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 11.10 | 2,639 | 29,293 | 2,638 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 9.65 | 13,448 | 129,773 | 5,000 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 9.42 | 11,883 | 111,938 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 7.96 | 2,294 | 18,260 | 8,750 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 6.30 | 13,920 | 87,696 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Option Exercise | M | 6.00 | 21,204 | 127,224 | 0 | |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 2,638 | 39,570 | 46,441 | 49.1 K to 46.4 K (-5.38 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 11.10 | 2,638 | 29,282 | 49,079 | 46.4 K to 49.1 K (+5.68 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 695 | 10,425 | 46,441 | 47.1 K to 46.4 K (-1.47 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 11.10 | 695 | 7,715 | 47,136 | 46.4 K to 47.1 K (+1.50 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 2,639 | 39,585 | 46,441 | 49.1 K to 46.4 K (-5.38 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 11.10 | 2,639 | 29,293 | 49,080 | 46.4 K to 49.1 K (+5.68 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 694 | 10,410 | 46,441 | 47.1 K to 46.4 K (-1.47 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 11.10 | 694 | 7,703 | 47,135 | 46.4 K to 47.1 K (+1.49 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 11,883 | 178,245 | 46,441 | 58.3 K to 46.4 K (-20.37 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 9.42 | 11,883 | 111,938 | 58,324 | 46.4 K to 58.3 K (+25.59 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 617 | 9,255 | 46,441 | 47.1 K to 46.4 K (-1.31 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 9.42 | 617 | 5,812 | 47,058 | 46.4 K to 47.1 K (+1.33 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 13,920 | 208,800 | 46,441 | 60.4 K to 46.4 K (-23.06 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 6.30 | 13,920 | 87,696 | 60,361 | 46.4 K to 60.4 K (+29.97 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 1,079 | 16,185 | 46,441 | 47.5 K to 46.4 K (-2.27 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 6.30 | 1,079 | 6,798 | 47,520 | 46.4 K to 47.5 K (+2.32 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 21,204 | 318,060 | 46,441 | 67.6 K to 46.4 K (-31.35 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 6.00 | 21,204 | 127,224 | 67,645 | 46.4 K to 67.6 K (+45.66 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 3,795 | 56,925 | 46,441 | 50.2 K to 46.4 K (-7.55 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 6.00 | 3,795 | 22,770 | 50,236 | 46.4 K to 50.2 K (+8.17 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 13,448 | 201,720 | 46,441 | 59.9 K to 46.4 K (-22.45 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 9.65 | 13,448 | 129,773 | 59,889 | 46.4 K to 59.9 K (+28.96 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 11,552 | 173,280 | 46,441 | 58 K to 46.4 K (-19.92 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 9.65 | 11,552 | 111,477 | 57,993 | 46.4 K to 58 K (+24.87 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 2,294 | 34,410 | 46,441 | 48.7 K to 46.4 K (-4.71 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 7.96 | 2,294 | 18,260 | 48,735 | 46.4 K to 48.7 K (+4.94 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 15,206 | 228,090 | 46,441 | 61.6 K to 46.4 K (-24.67 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 7.96 | 15,206 | 121,040 | 61,647 | 46.4 K to 61.6 K (+32.74 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Sell | S | 15.00 | 16,666 | 249,990 | 46,441 | 63.1 K to 46.4 K (-26.41 %) |
| Sep 01 2017 | CYTK | CYTOKINETICS INC | Morgan Bradley Paul | SVP Drug Discovery ... | Buy | M | 6.67 | 16,666 | 111,162 | 63,107 | 46.4 K to 63.1 K (+35.89 %) |